T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued to investors on Thursday. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

Shares of NASDAQ TTOO opened at $0.21 on Thursday. T2 Biosystems has a 12-month low of $0.20 and a 12-month high of $6.95. The stock’s 50 day simple moving average is $0.36 and its 200 day simple moving average is $1.65.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.